Pharsight

1. Nithiodote patents expiration

Application	Filing Date	Opposition Party	Legal Status

EP10797770A	2018-07-31	Shimamura, Naomi	Patent maintained as amended
EP10797770A	2018-07-30	Dr. Franz Köhler Chemie GmbH	Patent maintained as amended

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11753301	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Feb, 2030 (5 years from now)
US9585912	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)
US9345724	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)
US8496973	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Mar, 2031 (6 years from now)
US8568793	HOPE PHARMS	Sodium nitrite-containing pharmaceutical compositions	Dec, 2031 (7 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506	HOPE PHARMS	Sodium nitrite-containing pharmaceutical compositions	Feb, 2030 (5 years from now)
US10479686	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-5)	Jan 14, 2018
Orphan Drug Exclusivity(ODE)	Jan 14, 2018

Drugs and Companies using SODIUM NITRITE; SODIUM THIOSULFATE ingredient

Market Authorisation Date: 14 January, 2011

Treatment: Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning; Sodium thiosulfate injection is administered by intravenous injection; Tr...

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

Strength	Dosage	Availability
300MG/10ML(30MG/ML),N/A;N/A,12.5GM/50ML(250MG/ML)	SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS	Prescription

NITHIODOTE family patents

2. Sodium Nitrite patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8568793	HOPE PHARMS	Sodium nitrite-containing pharmaceutical compositions	Dec, 2031 (7 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506	HOPE PHARMS	Sodium nitrite-containing pharmaceutical compositions	Feb, 2030 (5 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-5)	Jan 14, 2018
Orphan Drug Exclusivity(ODE)	Jan 14, 2018

Drugs and Companies using SODIUM NITRITE ingredient

Market Authorisation Date: 14 February, 2012

Treatment: Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning

Dosage: SOLUTION;INTRAVENOUS

Strength	Dosage	Availability
300MG/10ML (30MG/ML)	SOLUTION;INTRAVENOUS	Prescription

SODIUM NITRITE family patents

3. Sodium Thiosulfate patents expiration

Application	Filing Date	Opposition Party	Legal Status

EP10797770A	2018-07-31	Shimamura, Naomi	Patent maintained as amended
EP10797770A	2018-07-30	Dr. Franz Köhler Chemie GmbH	Patent maintained as amended

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11753301	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Feb, 2030 (5 years from now)
US9585912	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)
US9345724	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)
US8496973	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Mar, 2031 (6 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10479686	HOPE PHARMS	Sodium thiosulfate-containing pharmaceutical compositions	Jul, 2030 (6 years from now)

Drug Exclusivity	Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-5)	Jan 14, 2018
Orphan Drug Exclusivity(ODE)	Jan 14, 2018

Drugs and Companies using SODIUM THIOSULFATE ingredient

Market Authorisation Date: 14 February, 2012

Treatment: Sodium thiosulfate injection is administered by intravenous injection; Sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning tha...